US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...

suppressing appetite and stimulating weight loss. The University of Copenhagen scientists — funded by Ozempic maker Novo ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Amgen stock rebounded Wednesday, shaking off "overdone" fears that its monthly weight-loss shot, MariTide, causes excessive bone mineral density loss.Please watch the video at Investors.com - How Novo ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Ozempic and similar medications are highly ... misinformation — and echo decades of flawed teachings on weight management. So ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Novo Nordisk is working on a new obesity drug that could ... Semaglutide, the GLP-1 drug that Novo sells under the brand ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...